Safety and Causal Prophylactic Efficacy of KAF156 in a Controlled Human Malaria Challenge Model
Clinical trial NCT04072302 · COMPLETED
Trial details
- NCT number
- NCT04072302
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-15
- Primary completion
- 2017-11-29
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.